title: Evans syndrome complicating fludarabine treatment for advanced B-CLL.
authors.forename: L
authors.initials: L
authors.lastname: Shvidel
authors.forename: M
authors.initials: M
authors.lastname: Shtarlid
authors.forename: A
authors.initials: A
authors.lastname: Klepfish
authors.forename: E
authors.initials: E
authors.lastname: Sigler
authors.forename: A
authors.initials: A
authors.lastname: Berrebi
mesh_terms: D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013577:Syndrome; D013921:Thrombocytopenia / Q000139:chemically induced*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine